A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
Part of paid clinical trials in Avondale, Arizona.
- Sponsor
- Amgen
- Study ID
- NCT06104124
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
- Sjogren's Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dazodalibep — DRUGIV infusion
- Placebo — DRUGIV infusion
Study Details
Primary Objective: To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity. Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) in participants with SS. 2. To evaluate the safety and tolerability of dazodalibep in participants with SS
Key Dates
- Start date
- Jan 24, 2024
- Status verified
- Jan 2026
- Primary completion
- Aug 19, 2026
- Completion
- Aug 19, 2026
Study Design
- Enrollment
- 651 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Dazodalibep Dose 1Participants will be administered dose 1 of dazodalibep by intravenous (IV) infusion.
- Experimental: Dazodalibep Dose 2Participants will be administered dose 2 of dazodalibep by IV infusion.
- Placebo Comparator: PlaceboParticipants will be administered placebo by IV infusion.
Primary Outcome Measure
Change from baseline in European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index (ESSDAI) Score [ Time Frame: At Week 48 ]
Locations (45)
Find similar trials in Avondale, AZ
By research site
Arizona Arthritis & Rheumatology Associates - Avondale· Avondale, AZArizona Research Clinic PLLC· Chandler, AZArizona Arthritis and Rheumatology Associates - Flagstaff - 399 S Malpais Ln· Flagstaff, AZArizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St· Gilbert, AZArizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln· Glendale, AZArizona Arthritis and Rheumatology Associates - Tucson - 2001 W Orange Grove Rd· Tucson, AZ
Related Studies
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Rheumatology Diet StudyRecruiting · University of Central Florida · Orlando, Florida
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseasePHASE1 · Recruiting · Cullinan Therapeutics Inc. · Orlando, Florida
- The Pathogenesis and Natural History of Sjogren's DiseaseRecruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland